After consulting with AIDS organisations across Europe, EURORDIS conveyed the following feedback to the committee: “AIDS groups were not convinced of the utility of recombinant human growth hormone (rhGH) for treating HIV cachexia or AIDS wasting syndrome, even though AIDS wasting remained a reality. This evidence concerns the gene GH1 and Cachexia.